Sequelae

Objective To estimate the risks of incident mental health disorders in survivors of the acute phase of covid-19. Design Cohort study. // 16.2.2022

A 58-year-old woman who died of COVID infection was included as a control subject in an ongoing autopsy study of the neuropathology of military traumatic brain // 14.2.2022

Background COVID-19 sequelae are poorly defined with an ambiguous pathophysiology. Persistent sequelae could have global, public health and societal ramifications. We aimed to describe sequelae presenting more than six months after COVID-19 in non-hospitalized young adults. // 13.2.2022

A new study estimated the risk and hazards of persistent and new clinical sequelae of the SARS-CoV-2 infection among elderly patients (above 65 years or older) during the post-acute phase of the infection. // 11.2.2022

Almost a third (32 of every 100) of older adults infected with covid-19 in 2020 developed at least one new condition that required medical attention in the months after initial infection, 11 more than those who did not have covid-19, finds a US study published by The BMJ today. // 10.2.2022

Objective To characterize the risk of persistent and new clinical sequelae in adults aged ≥65 years after the acute phase of SARS-CoV-2 infection. Design Retrospective cohort study. // 9.2.2022

Nature Medicine - Individuals with COVID-19 are at increased long-term risk for a wide range of cardiovascular disorders, even for individuals who were not hospitalized during the acute phase of... // 7.2.2022

Researchers in the United Kingdom have conducted an observational cohort study on hospitalized patients and have found that the degree of severity of acute coronavirus disease 2019 (COVID-19) predicts the occurrence of chronic cerebrovascular impairment. The study further suggests that the levels of cerebrovascular impairment are associated with worse cognitive, mental, and physical well-being. // 7.2.2022

A recent study explored whether individuals who have recovered from mild to moderate or severe COVID-19 may have an increased risk for developing Parkinson’s disease in the future. // 7.2.2022

Nearly 60% of former ICU patients reported continuing sickness-related problems at work. Three-fourths reported physical problems, and 26% reported mental problems. // 25.1.2022

A group of researchers used the golden hamster as a model system to better understand the long-term impacts of SARS-CoV-2 infection. // 24.1.2022

A team of researchers recently provided insights into central nervous system consequences of the coronavirus disease 2019 (COVID-19) in a perspective paper published in the Science journal. // 24.1.2022

A new review article investigated the relation between SARS-CoV-2 infection and reproductive health. // 19.1.2022

Although the inflammation improved over time in the study, the long-term consequences are not known, the authors warn. // 13.1.2022

Introduction Neurological complications among hospitalized COVID-19 patients may be associated with elevated neurodegenerative biomarkers. // 13.1.2022

The new research findings, although preliminary, raise concerns about the potential long-term effects of COVID-19, a Texas A&M cognitive neuroscientist says. // 24.9.2022

Some patients who develop new cognitive symptoms after a mild bout of COVID have abnormalities in their cerebrospinal fluid similar to those found in people with other infectious diseases. // 18.1.2022

This cohort study examines myocardial metabolic changes early after recovery from COVID-19 using fluorodeoxyglucose–positron emission tomography (PET) and shows an association of these changes with abnormalities in cardiac magnetic resonance imaging (MRI)–based function and tissue characterization... // 12.1.2022

In Italian study, over half had metabolic dysfunction-associated fatty liver disease // 11.1.2022

Survivors of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) infection frequently experience lingering neurological symptoms, including impairment in attention, concentration, speed of information processing and memory. // 10.1.2022

Prominent clinical symptoms of COVID-19 include CNS manifestations. However, it is unclear whether severe acute respiratory syndrome coronavirus 2 (SA… // Nov. 2020

Those with prior infection, regardless of symptom severity, reported significantly more symptoms of cognitive dysfunction than did non-infected counterparts in the general population. // 4.1.2022

The coronavirus pandemic has increased general interest in how viruses enter the brain, and what their effects on the brain are. There are receptors on the surface of some brain cells which allow the coronavirus to penetrate the cell. // 8.4.2021

COVID-19 can cause severe neurological symptoms, but the underlying pathophysiological mechanisms are unclear. // 13.7.2021

This report describes how children and adolescents were more likely to receive a new diabetes diagnosis after infection with SARS-CoV-2, the virus that causes COVID-19. // 7.1.2022

Nature Metabolism - Severe COVID-19 is often associated with detrimental elevations in blood glucose, but the mechanisms are poorly understood. // 6.1.2022

Potilaan sairastama diabetes on tunnetusti – sydänsairauksien ja lihavuuden ohella – vakavien koronavirusinfektioiden ja kuoleman riskitekijä. // 13.7.2020

Loss of taste not always due to loss of smell // 6.1.2022

Vakavasti sairastuneilla on suurempi riski ahdistukseen, masennukseen ja kognitiivisiin häiriöihin. // 6.1.2022

Oireiden syntymekanismi voi olla yhteydessä viruksen aiheuttamaan tulehdustilaan. // 4.1.2022